VericelVCEL +7.76%81 Days Inventory is 85.52 as of Mar. 2026, which is 9% above its 10-year median of 78.31. GuruFocus rates VCEL with a GF Score™ of 81/100 and a GF Value™ of $54.29 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 640 Biotechnology companies, Vericel ranks better than 75% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Vericel's Average Total Inventories for the
three
months ended in Mar. 2026 was $18.0 Mil. Vericel's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $19.2 Mil.
Hence, Vericel's Days Inventory for the
three
months ended in Mar. 2026 was 85.52.
The historical rank and industry rank for Vericel's Days Inventory or its related term are showing as below:
VCEL'
s Days Inventory Range Over the Past 10 Years
Min: 31.38 Med: 78.31 Max: 98.2
Current: 87.41
During the past 13 years, Vericel's highest Days Inventory was 98.20. The lowest was 31.38. And the median was 78.31.
VCEL's Days Inventory is ranked better than 75% of 640
companies
in the Biotechnology industry
Industry Median: 184.145
vs VCEL: 87.41
Vericel's Days Inventory
declined
from Mar. 2025 (96.36) to Mar. 2026 (85.52).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Vericel's Inventory Turnover for the
three
months ended in Mar. 2026 was 1.07.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Vericel's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.26.
Vericel (NAS:VCEL) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Vericel's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Vericel's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Vericel Days Inventory Related Terms
Vericel Days Inventory Historical Data
* Premium members only.
The historical data trend for Vericel's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VCEL vs PVLA, TSHA, GENB: Days Inventory Comparison
For the Biotechnology subindustry, Vericel's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vericel Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Vericel's Days Inventory distribution charts can be found below:
* The bar in red indicates where Vericel's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vericel (VCEL) has a Days Inventory of 85.52 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Vericel and its competitors. This is near median its historical median of 78.31. Over the past decade, Vericel's Days Inventory has ranged from 31.38 to 98.20. According to the industry distribution chart, Vericel ranks #160 out of 640 companies in the Biotechnology industry, placing it in the top 25%.
Is Vericel's Days Inventory too high?
Vericel's current Days Inventory of 85.52 is near median its 10-year median of 78.31. Over the past 10 years, this metric has ranged from a low of 31.38 to a high of 98.20. The Biotechnology industry median Days Inventory is 184.15. Vericel's value of 85.52 is 53.6% below this industry median. Based on the distribution chart, Vericel ranks #160 out of 640 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Vericel has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vericel's Days Inventory compare to PVLA and TSHA?
According to the Biotechnology industry distribution chart, Vericel ranks #160 out of 640 companies for Days Inventory. This places Vericel in the top 25% of its industry — outperforming the majority of peers. The industry median Days Inventory is 184.15. Vericel's value of 85.52 is 53.6% below this benchmark. Historically, Vericel's own Days Inventory has ranged from 31.38 to 98.20 over the past decade. While the company's 10-year median is 78.31 vs. the industry median of 184.15, Vericel has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 184.15, based on 640 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vericel's current Days Inventory of 85.52 is 53.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Vericel and its competitors. For the Biotechnology industry, the median Days Inventory is 184.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vericel's current Days Inventory is 85.52, which is near median its own 10-year median of 78.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vericel stock overvalued right now?
Based on GuruFocus' analysis, Vericel (VCEL) is currently considered Modestly Undervalued. The stock's GF Value™ is $54.29, compared to a current price of $46.23 — trading 14.8% below its estimated fair value. The current Days Inventory is 85.52, which is near median its 10-year median of 78.31 and 53.6% below the Biotechnology industry median of 184.15. Vericel's overall GF Score™ is 81/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Vericel (VCEL), the current Days Inventory is 85.52 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vericel (VCEL) Overvalued in 2026?
Based on GuruFocus' analysis, Vericel stock appears to be undervalued.
The current stock price of $46.23 is trading 14.8% below its estimated GF Value™ of $54.29.
GuruFocus considers Vericel to be Modestly Undervalued.
Key valuation signals for VCEL:
Days Inventory: 85.52 (near median its 10-year median of 78.31)
GF Value™: $54.29 vs. price of $46.23 (14.8% below fair value)
Industry Position: 53.6% below the Biotechnology median (#160 of 640)
No single metric tells the full story. See the VCEL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
81GF Score
Get the complete analysis for VCEL
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VCEL has been successfully added to your 
